CVI42 vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CVI42

by Circle Cardiovascular Imaging Inc.

VX1+

by Volta Medical

AI Verdict

CVI42 is designed for comprehensive cardiac and vascular imaging analysis, aiding in diagnosis and planning through advanced CT and MRI tools. In contrast, VX1+ provides real-time AI assistance to electrophysiologists during cardiac ablation procedures by identifying abnormal electrograms. While both are cardiology AI tools, they address distinct clinical phases and data types, making them complementary rather than direct competitors.

Choose CVI42 if…

Choose CVI42 if your primary need is comprehensive, AI-enabled analysis of cardiac and vascular imaging data from CT and MRI scans. This tool is ideal for enhancing diagnosis, pre-procedural planning, and patient care through advanced features like automated coronary plaque analysis and sophisticated CMR automation. It is best suited for clinicians requiring detailed anatomical and functional insights from imaging studies.

View CVI42 →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist seeking real-time, AI-powered assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia. This software excels at identifying abnormal electrograms and providing AI-driven insights directly within your existing EP recording and 3D mapping systems. It is specifically designed to enhance precision and efficiency during the ablation procedure itself.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CVI42	VX1+
Pricing	Starts at $5,000 per license.	Unknown
Deployment	On-premise (standalone workstation or client/server)	Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CVI42

CVI42 is consistently described as having an 'advanced algorithms and user-friendly interface' and 'intuitive post-processing analysis' for comprehensive imaging tasks. It offers 2D and 3D visualization, diverse measurement tools, and supports multiple languages and deployment options, suggesting a well-rounded and accessible platform for complex analysis. While VX1+ emphasizes a 'simple user interface' for real-time procedural assistance, CVI42's broader feature set and consistent positive feedback on ease of use for advanced functions give it an edge.

Clinical Value

Tie

Both tools offer significant and distinct clinical value. CVI42 enhances diagnosis, planning, and patient care through comprehensive cardiac and vascular imaging analysis, including AI-automated plaque analysis with strong reimbursement potential and clinical validation. VX1+ provides real-time AI-driven insights to electrophysiologists during cardiac ablation procedures, with published clinical validation demonstrating its reliability in identifying abnormal electrograms and contributing to positive patient outcomes. Their value is equally critical within their specialized domains.

Pricing & Value

CVI42

CVI42 offers more transparency regarding its pricing model, detailing a flexible subscription that scales across service lines and requires additional licenses for specific modules. Crucially, the availability of new CPT codes for AI-enabled coronary plaque analysis directly links CVI42 to reliable revenue streams and accelerated ROI for customers. VX1+ provides no public pricing information or details on its pricing structure, making its value proposition less clear.

Enterprise Readiness

CVI42

CVI42 demonstrates stronger enterprise readiness with its comprehensive integration capabilities (DICOM, HL7, PACS/VNA, EMR), vendor-neutrality, and a clear on-premise architecture that ensures data security by keeping all PHI local and not transmitting data outside the institution. It also holds ISO 13485:2016 and MDSAP certificates, aligning with global medical device regulations. While VX1+ integrates with existing EP systems, its HIPAA compliance is less explicitly stated, relying on provider contracts rather than a direct BAA disclosure.

Innovation

VX1+

Both tools are highly innovative. CVI42 offers advanced AI-driven comprehensive cardiovascular imaging analysis, including plaque and vascular analysis, with a focus on automation and reproducibility. However, VX1+ stands out for bringing real-time AI decision support directly into the electrophysiology lab during live ablation procedures, being the first FDA-cleared AI tool in this interventional space. This immediate, in-procedure impact gives VX1+ a slight edge in terms of groundbreaking innovation.

Support & Docs

CVI42

CVI42 clearly outlines its support offerings, including live chat, help guides, webinars, on-site training, and global technical support available in multiple languages and time zones. Extensive documentation, such as user manuals and installation guides, is also readily available online. In contrast, no specific information regarding customer support or documentation for VX1+ was found in the provided facts or search results.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CVI42	VX1+
Product Name	CVI42	VX1+
Company	CIRCLE CARDIOVASCULAR IMAGING	Volta Medical
Primary Use Case	AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools.	AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and and atrial tachycardia.
Target Medical Specialties	Cardiology, Cardiothoracic Surgery, Radiology	Cardiology
Key AI-driven Analysis	AI-automated coronary lumen and wall segmentation, comprehensive coronary plaque analysis, advanced CMR automation (T1 mapping, 4D flow pre-processing), automated detection of suspected coronary lesions.	Real-time manual or automatic annotation of 3D anatomical and electrical maps, identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, AI-driven insights to assist electrophysiologists during ablation procedures.

Videos

Demos, reviews, and walkthroughs featuring CVI42 and VX1+.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for cardiac patient management, considering their different clinical contexts?

CVI42 is designed for comprehensive cardiac and vascular imaging analysis, integrating seamlessly into existing CCTA workflows and PACS and reporting systems like PowerScribe One to optimize diagnostic interpretation and reporting. VX1+ is specifically designed for real-time assistance during cardiac ablation procedures for atrial fibrillation and atrial tachycardia, integrating with existing EP recording and 3D mapping systems to guide interventions.

What is the depth of integration with existing hospital IT infrastructure, specifically beyond imaging and EP mapping systems, to ensure seamless data flow to the EHR?

CVI42 integrates directly into existing PACS and reporting systems, aiming for a fully connected imaging workflow and reducing the time from 'scan to report'. VX1+ integrates with existing EP recording and 3D mapping systems, but direct EHR integration is not explicitly detailed in the provided information.

What specific clinical evidence or performance metrics are available regarding the accuracy and sensitivity of CVI42's AI for lesion detection and plaque analysis, versus VX1+'s ability to identify dispersed electrograms in real-time?

CVI42's AI-enabled coronary plaque quantification delivers fast, accurate, and reproducible results for quantifying total, calcified, and non-calcified plaque, supporting precise risk stratification. VX1+ utilizes machine learning, including deep learning algorithms, to detect abnormal signals and identify spatio-temporal dispersed electrograms in real-time during AF and AT procedures, with clinical validation studies demonstrating its feasibility and relevance in standardizing ablation outcomes.

Given CVI42's broad application across cardiac imaging and VX1+'s specific focus on electrophysiology, what is the expected learning curve for physicians in each specialty to achieve proficiency with these respective tools?

CVI42 is designed for workflow optimization and ease of use, with automated AI features to streamline analysis, though full standardization across imaging may involve adapting to new modules. VX1+ is described as intuitive and user-friendly, with its algorithms trained on a large database of electrograms annotated by expert electrophysiologists, which allows for a fast learning curve and standardized outcomes.

For a multi-site healthcare system, what considerations should be made regarding the time-to-value and complexity of rolling out CVI42 across different imaging modalities versus deploying VX1+ in multiple EP labs?

CVI42 is a unified platform designed to scale across CT and MR service lines, aiming to reduce reporting times and improve workflow efficiency across multidisciplinary teams, with a global team offering support for its widespread use. VX1+ is a software application compatible with existing EP systems, and its design for real-time procedural assistance suggests it could be deployed in multiple EP labs, though specific multi-site rollout considerations for time-to-value are not detailed.